<DOC>
	<DOCNO>NCT00002170</DOCNO>
	<brief_summary>The purpose study see safe effective give Viracept AIDS patient treat MAC .</brief_summary>
	<brief_title>A Study Viracept AIDS Patients With Mycobacterium Avium Complex Disease ( MAC )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<mesh_term>Opportunistic Infections</mesh_term>
	<mesh_term>Mycobacterium avium-intracellulare Infection</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection New diagnosis MAC bacteremia &lt; 7 day therapy . Prior Medication : Allowed : Patients 7 day therapy MAC disease . Exclusion Criteria Prior Medication : Excluded : Prior therapy ( le 2 week ) protease inhibitor saquinavir .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 1999</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Placebos</keyword>
	<keyword>Mycobacterium avium-intracellulare Infection</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Nelfinavir</keyword>
	<keyword>Anti-Infective Agents</keyword>
	<keyword>Anti-HIV Agents</keyword>
</DOC>